United Therapeutics (UTHR) Other Working Capital Changes (2016 - 2025)
Historic Other Working Capital Changes for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to -$67.2 million.
- United Therapeutics' Other Working Capital Changes fell 5849.06% to -$67.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year decrease of 6688.96%. This contributed to the annual value of $55.6 million for FY2024, which is 3285.02% down from last year.
- Per United Therapeutics' latest filing, its Other Working Capital Changes stood at -$67.2 million for Q3 2025, which was down 5849.06% from $184.4 million recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Other Working Capital Changes registered a high of $184.4 million during Q2 2025, and its lowest value of -$134.5 million during Q1 2025.
- Moreover, its 5-year median value for Other Working Capital Changes was $12.6 million (2021), whereas its average is $20.2 million.
- In the last 5 years, United Therapeutics' Other Working Capital Changes soared by 64841.27% in 2022 and then tumbled by 108604.65% in 2024.
- United Therapeutics' Other Working Capital Changes (Quarter) stood at $12.6 million in 2021, then soared by 648.41% to $94.3 million in 2022, then plummeted by 56.2% to $41.3 million in 2023, then fell by 10.17% to $37.1 million in 2024, then tumbled by 281.13% to -$67.2 million in 2025.
- Its Other Working Capital Changes was -$67.2 million in Q3 2025, compared to $184.4 million in Q2 2025 and -$134.5 million in Q1 2025.